Welcome to CDC stacks | FLUCELVAX QUADRIVALENT® (influenza vaccine) -CCIIV4 - 60665 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
FLUCELVAX QUADRIVALENT® (influenza vaccine) -CCIIV4
Filetype[PDF-1.19 MB]


Details:
  • Supporting Files:
    No Additional Files
    1. Influenza Work Group introduction
      Personal Author:
      Karron, Ruth A.
      Corporate Author:
      United States. Advisory Committee on Immunization Practices. Influenza Workgroup.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
      Published:
      June 22, 2016
      Series:
      ACIP meeting Influenza
      File Type:
      Filetype[PDF - 49.92 KB]
    2. Immunogenicity and safety of GSK’s FluLaval™ quadrivalent inactivated influenza vaccine in children 6-35 months of age
      Personal Author:
      Innis, Bruce L.
      Corporate Author:
      GSK Vaccines.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
      Published:
      June 22, 2016
      Series:
      ACIP meeting Influenza
      File Type:
      Filetype[PDF - 541.10 KB]
    3. Influenza vaccine effectiveness, including LAIV vs IIV in children and adolescents, US Flu VE Network, 2015-16
      Personal Author:
      Flannery, Brendan; Chung, Jessie R.;
      Corporate Author:
      National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
      Published:
      June 22, 2016
      Series:
      ACIP meeting Influenza
      File Type:
      Filetype[PDF - 332.39 KB]
    4. LAIV vs IIV effectiveness : summary of evidence since 2009
      Personal Author:
      Flannery, Brendan
      Corporate Author:
      National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
      Published:
      June 22, 2016
      Series:
      ACIP meeting Influenza
      File Type:
      Filetype[PDF - 218.44 KB]
    5. End-of-season update : 2015-2016 influenza vaccine safety monitoring
      Personal Author:
      Shimabukuro, Tom T.
      Corporate Author:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
      Published:
      June 22, 2016
      Series:
      ACIP meeting Influenza
      File Type:
      Filetype[PDF - 176.94 KB]
    6. 2015-16 US influenza vaccine effectiveness influenza clinical investigation for children (ICICLE) study
      Personal Author:
      Ambrose, Chris
      Corporate Author:
      AstraZeneca (Firm)
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
      Published:
      June 22, 2016
      Series:
      ACIP meeting Influenza
      File Type:
      Filetype[PDF - 739.86 KB]
    7. LAIV effectiveness : WG discussion
      Personal Author:
      Grohskopf, Lisa A
      Corporate Author:
      United States. Advisory Committee on Immunization Practices. Influenza Work Group .
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
      Published:
      June 22, 2016
      Series:
      ACIP meeting Influenza
      Description:
      Author's name from meeting agenda.
      File Type:
      Filetype[PDF - 151.12 KB]
You May Also Like:
  1. Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness
    Personal Author:
    Barr, Ian G.; Donis, Ruben O.; Katz, Jacqueline M.; McCauley, John W.; Odagiri, Takato; Trusheim, Heidi; Tsai, Theodore F.; Wentworth, David E.;
    Published:
    Oct 09 2018
    Source:
    NPJ Vaccines. 3.
    Description:
    The 2017-2018 seasonal influenza epidemics were severe in the US and Australia where the A(H3N2) subtype viruses predominated. Although circulating A(H3N2) viruses did not differ antigenically from that recommended by the WHO for vaccine production, ...
    File Type:
    Filetype[PDF - 516.16 KB]
  2. Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2018-19
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    8-23-2018
    Description:
    updated 8-23-2018 : For additional information: MMWR Recomm Rep 2018;67(No. RR-3) (https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html) Note: The contents of this document are available in HTML format at https://www.cdc.gov/flu/professi...
    File Type:
    Filetype[PDF - 1.29 MB]
  3. Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices -- United States, 2016-17 influenza season
    Personal Author:
    Grohskopf, Lisa A.; Sokolow, Leslie Z.; Broder, Karen R.; Olson, Sonja J.; Karron, Ruth A.; Jernigan, Daniel B.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division..
    Published:
    August 26, 2016
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 65, no. RR-5
    Description:
    This report updates the 2015–16 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines (Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control...
    Status:
    superseded
    File Type:
    Filetype[PDF - 608.76 KB]
  4. Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 influenza season
    Personal Author:
    Grohskopf, Lisa A.; Sokolow, Leslie Z.; Broder, Karen R.; Walter, Emmanuel B.; Bresee, Joseph S.; Fry, Alicia M.; Jernigan, Daniel B.;
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division..
    Published:
    August 25, 2017
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 66, no. RR-2
    Description:
    This report updates the 2016–17 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines (MMWR Recomm Rep 2016;65[No. RR-5]). Routine annual influenza vaccination is recommended for...
    Status:
    current
    File Type:
    Filetype[PDF - 315.47 KB]
  5. Advisory Committee on Immunization Practices (ACIP) summary report : June 22-23, 2016, Atlanta, Georgia
    Personal Author:
    Anand, Abhijeet
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2016 June 22-23 : Atlanta, GA)
    Published:
    12/15/16
    Series:
    ACIP meeting Minutes
    Description:
    Advisory Committee On Immunization Practices (ACIP) - June 2016 Meeting Minutes : Publication date from document properties. : min-2016-06.pdf
    File Type:
    Filetype[PDF - 3.10 MB]